XML Persian Abstract Print

Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran , abbasi.f@umsu.ac.ir
Abstract:   (1394 Views)
Background & Aims: To determine how well the standard criteria were utilized in reporting breast cancer pathology and to compare the variability among a public teaching, a public nonteaching, and a private hospital in Urmia, Iran.
Materials & Methods: Three hundred and fifty pathology reports of mastectomy samples with diagnosis of primary breast cancer were retrieved from archives of pathology departments of three hospitals; one public teaching (121 reports), one public nonteaching (99 reports), and one private hospital (130 reports). The reports were assessed for tumor laterality, size, color, consistency, type and grade, sample size, description of prior biopsy site, specimen condition (fresh, or in fixative), number of excised and involved lymph nodes, previous frozen section (FS), surgical margins, lymphovascular invasion, and in situ carcinoma.
Results: None of the reports had all the suggested items. Specimen condition was the only item recorded in all of the reports. The teaching hospital reports had significantly higher number of reported items than the two other hospitals (P<0.001). Key items (tumor size, type and grade, surgical margin, vascular invasion, and in situ carcinoma) were also indicated more frequently in teaching hospital (P<0.001).
Conclusion: We showed evident variations in reporting breast cancer pathology in the studied different hospitals. It seems that the teaching program in the public-teaching hospital can be a reason for the better results in this hospital. So we suggest using standard universal protocols for cancer reporting as well as creating an effective audit system to evaluate complete utilization of the protocols.
Full-Text [PDF 256 kb]   (610 Downloads)    
Type of Study: orginal article | Subject: General

1. Jazayeri, SB, Saadat, S, Ramezani, R, Kaviani, A, Incidence of primary breast cancer in Iran: Ten- year national cancer registry data report. Cancer Epidemiol 2015;39(4):519-27. [DOI:10.1016/j.canep.2015.04.016] [PMID]
2. Mousavi, SM, Montazeri, A, Mohagheghi, MA, Jarrahi, AM, Harirchi, I, Najafi, M, et al, Breast cancer in Iran: An Epidemiological Review. Breast J 2007;13(4):383-91. [DOI:10.1111/j.1524-4741.2007.00446.x] [PMID]
3. Lester SC. The Breast. In: Kumar V, Abbas AK, Aster JC, eds. Robbins basic pathology 9th ed. Canada: Elsevier Saunders; 2015:1043-50. [URL]
4. Kolahdoozan, S, Sadjadi, A, Radmard, AR, Khademi, H, Five common cancers in Iran. Arch Iran Med 2010;13(2):143-46. [URL]
5. Wilkinson, NW, Shahryarinejad, A, Winston, JS, Watroba, N, Edge, SB, Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg 2003;196(1):38-43. [DOI:10.1016/S1072-7515(02)01627-7] [PMID]
6. Cancer Reporting and Biomarker Reporting Protocols [available from: cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-template]
7. Kricker, A, Armstrong, B, Smith, C, Bilous, M, Camaris, C, Mayer, A, et al, An audit of breast cancer pathology reporting in Australia in 1995. Br J Cancer 1999;80(3/4):563-68 [DOI:10.1038/sj.bjc.6690392] [PMID] [PMCID]
8. Apple, SK, Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue. Breast J 2006;12(2):145-9. [DOI:10.1111/j.1075-122X.2006.00222.x] [PMID]
9. Masood, S, Vass, L, Ibarra, JA, Ljung, BM, Stalsberg, H, Eniu, A, et al, Breast Pathology Guideline Implementation in Low- and Middle-Income Countries. Cancer 2008;113(8 Suppl):2297-304. [DOI:10.1002/cncr.23833] [PMID]
10. Goldsmith, JD, Siegal, GP, Suster, S, Wheeler, TM, Brown, RW, et al, Surgical pathology report recommendations. Arch Pathol lab Med J 2008; 132:1608-16. [DOI:10.5858/2008-132-1608-RGFCLR] [PMID]
11. Atanda, AT, Atanda, JO, Audit of Histopathology reports for breast cancer in Aminukano teaching hospital. West Afr J Med 2010;29(3):174-77. [DOI:10.55891/wajm.v29i3.2]
12. Mathers, ME, Shrimankar, J, Scott, DJ, Charlton, FG, Griffith, CD, Angus, B, The use of a standard proforma in breast cancer reporting. Clin Pathol 2001; 54:809-11. [DOI:10.1136/jcp.54.10.809] [PMID] [PMCID]
13. Kadivar, M, Kheirkhah Rahimabad, P, Missing elements in surgical pathology reports: breast, colon and stomach cancers. Asian Pac J Cancer Prev 2016; 17:1469-72 [DOI:10.7314/APJCP.2016.17.3.1469] [PMID]
14. Idowu, MO, Bekeris, LG, Raab, S, Ruby, SG, Nakhleh, RE, Adequacy of Surgical Pathology Reporting of Cancer. Arch Pathol Lab Med 2010; 134:969-74. [DOI:10.5858/2009-0412-CP.1] [PMID]
15. Austin, R, Thompson, B, Coory, M, Walpole, E, Francis, G, Fritschi, L, Histopathology reporting of breast cancer in Queensland: the impact on the quality of reporting as a result of the introduction of recommendations. Pathology 2009;41(4):361-65. [DOI:10.1080/00313020902884469] [PMID]
16. Bilous, M, McCredite, M, Porter, L, Adequacy of histopathology reports for breast cancer in New South Wales. Pathology 1995;27(4):306-11. [DOI:10.1080/00313029500169193] [PMID]
17. Soerjomataram, I, Louwman, MWJ, Ribot, JG, Roukema, JA, Coebergh, JW, An Overview of prognostic factors for long-term survivors of breast cancer. Breast cancer Res Treat 2008;107:309-30. [DOI:10.1007/s10549-007-9556-1] [PMID] [PMCID]
18. Ran, S, Volk, L, Hall, K, Flister, MJ, Flzter. Lymphangiogenesis and lymphatic metastasis in Breast cancer. Pathophysiology 2010;17(4):229-51. [DOI:10.1016/j.pathophys.2009.11.003] [PMID] [PMCID]
19. Persing, S, James, TA, Mace, J, Goodwin, A, Geller, B, Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann Surg Oncol 2011;18(11):3061-65. [DOI:10.1245/s10434-011-1916-8] [PMID] [PMCID]
20. Onerheim, R, Racette, P, Jacques, A, Gagnon, R, Improving the quality of surgical pathology reports for breast cancer. Arch Pathol lab Med 2008;132:1428-31. [DOI:10.5858/2008-132-1428-ITQOSP] [PMID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.